contact us



A better Vision = A better Future

Through Innovation and Technology

is an international, full-service, technology-driven Contract Research & Development Organization (including cGMP IMP Services) providing technological services and solutions throughout the entire drug discovery & development cycle – from Preclinical to Market Access.

THERAMetrics works in collaboration with pharmaceutical, biotechnology and medical device Companies of all sizes to help accelerate the drug development process in the most profitable way.

Thanks to our concept “A better Vision = A better Future”, THERAMetrics is unique in its action plan. Because THERAMetrics believes that understanding its Customer's needs is the key success factor of a better Future, THERAMetrics opts for a wider angle of solutions to make its Customers reduce their TIME and COSTS.

THERAMetrics is a multi-functional group focused on four different clinical research segments:

1.  Contract Research Organization: THERAMetrics’ high-quality and cost-effective full-service Contract Research Organization provides worldwide services such as international project management, regulatory support, study activation, monitoring, data management, medical coding, medical review, pharmacovigilance/drug safety, statistics and medical writing. To read more please click here.

2.  Clinical Supply Services: THERAMetrics’ Clinical Supply Services (CSS) allows Customers to shorten their timelines and to reduce costs related to packaging, labeling and logistics of the Investigational Medicinal Product. To read more please click here.

3. Early Clinical Services: THERAMetrics has its own Clinical Research Units (CRU) for healthy volunteers, patients and special population offering an interdisciplinary team of experts who carries out safely and effectively Phase I and early Phases II and III in accordance to Good Clinical Practice (GCP) for a wide range of research fields. To read more please click here.

4.  Drug Discovery: THERAMetrics provides an innovative approach to Clinical Research through its Drug Repositioning and Repurposing system (DRR 2.0) and integrated Clinical Development Services (iCDS). To read more please click here.